Transient abnormal myelopoiesis/acute megakaryoblastic leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing
暂无分享,去创建一个
K. Kagan | F. Fend | A. Fasan | B. Federmann | S. Haen
[1] A. Tzankov,et al. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21. , 2014, Human pathology.
[2] A. Curley,et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. , 2013, Blood.
[3] M. Bythell,et al. Predictors of Survival in Children Born With Down Syndrome: A Registry-Based Study , 2012, Pediatrics.
[4] P. Vyas,et al. Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML , 2008, Leukemia.
[5] D. Reinhardt,et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. , 2008, Blood.
[6] P. Vyas,et al. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome , 2007, Nature Clinical Practice Oncology.
[7] S. Scherer,et al. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. , 2003, Blood.
[8] G. de Jong,et al. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks' gestation with Down syndrome: case report and review of the literature , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[9] A. Zipursky,et al. Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21 , 2003, British journal of haematology.
[10] H. Hasle,et al. Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.
[11] E. Niebuhr,et al. Down's syndrome , 1974, Humangenetik.